Stock Market Summary – October 27, 2025

Stocks surged to new highs on Monday following an easing of US-China trade tensions. The S&P 500 climbed 1.2% to close at its first ever high over 6,800 at 6,875.12. The Nasdaq Composite also jumped 1.9% to 23,637.46, with Nvidia and other chip stocks significantly contributing. Simultaneously, the Dow Jones Industrial Average rallied by 337.47 points, reaching 47,544.59 – another record close.

In contrast, Amazon shares rose 1.2% despite the news of 30,000 impending job cuts in an effort to offset hiring excesses during the pandemic’s peak demand. The cuts, set to begin Tuesday, represent nearly 10% of the company’s corporate workforce. The layoffs occur as CEO Andy Jassy embarks on a strategy to reduce bureaucracy within Amazon.

Artificial Intelligence (AI) is yielding significant productivity gains for large firms such as Amazon, while smaller companies lag. Following the introduction of OpenAI’s ChatGPT model in 2022, productivity for the S&P 500 soared by 5.5%, whereas it sank by 12.3% for the Russell 2000. Anticipated job cuts due to AI advancements have made news in firms like Target, Meta, Starbucks, Oracle, Microsoft, and UPS, with Amazon expected to replace over half a million jobs with robots for significant cost savings.

iRobot shares plummeted by over 30% after negotiations with an interested buyer ceased, leaving the company’s financial future uncertain. Meanwhile, the NBA is examining betting protocols in the wake of insider information leaked to gamblers. The review will explore the use of AI to identify suspicious betting patterns.

In the financial sector, another expected federal fund rate cut by the Federal Reserve could reduce consumer loan costs slightly.

Mercor, an AI start-up, achieved a $10 billion valuation following its latest $350 million funding round. The company plans to hire highly skilled professionals to train AI models.

In stock movements, Qualcomm surged by over 11% after announcing AI processors to compete with AMD and Nvidia. Conversely, Intellia Therapeutics dropped by 45% due to an unexpected halt in its patient dosing for Phase 3 clinical trials. Other losers in stocks include iRobot (30% drop) and Beyond Meat (9% drop), while gainers included Five Below (over 2% rise), Fermi (briefly climbed by 9%), and Dyne Therapeutics (41% rise).